Skip to main content
Log in

Comparative pharmacokinetics of the anticoagulant effect of coumarin drugs in man and rat

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The pharmacokinetic characterization of coumarin drugs may be used as an example of how one may analyze the time course of an indirect effect, having no apparent relationship to the drug concentrations in the plasma, such as is seen for the lowering of prothrombin complex activity. Resolution of the data into measures of the “direct” effect (i.e., inhibition of synthesis of clotting factor activity) permits excellent correlation between effect and drug concentration. The parallel development of a suitable animal model (the rat) has provided the opportunity to study the pharmacokinetics of the anticoagulant effect of the coumarin drugs and of their interaction with other drugs not only in the plasma but also at the tissue level. Selected results of an examination of the kinetics of drug distribution and elimination as well as the kinetics of drug action in both man and animals are presented here for the coumarin drugs as an example of a comprehensive pharmacokinetic investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. R. A. O'Reilly and P. M. Aggeler. Determinants of the response to oral anticoagulant drugs in man.Pharmacol. Rev. 22: 35–96 (1970).

    PubMed  Google Scholar 

  2. R. A. O'Reilly, E. Nelson, and G. Levy. Physicochemical and physiologic factors affecting the absorption of warfarin in man.J. Pharm. Sci. 55: 435–437 (1966).

    Article  PubMed  Google Scholar 

  3. R. A. O'Reilly, P. M. Aggeler, and L. S. Leong. Studies on the coumarin anticoagulant drugs: Comparison of the pharmacodynamics of dicumarol and warfarin in man.Thromb. Diath. Haemorrh. 11: 1–22 (1964).

    PubMed  Google Scholar 

  4. G. Levy. Dose dependent effects in pharmacokinetics. InImportance of Fundamental Principles in Drug Evaluation (D. H. Tedeschi and R. E. Tedeschi, eds.), Raven Press, New York, 1968, pp. 141–172.

    Google Scholar 

  5. G. Levy, T. Tsuchiya, and L. P. Amsel. Limited capacity for salicylic acid conjugation with glycine in man.Clin. Pharmacol. Therap. 13: 258–268 (1972).

    CAS  Google Scholar 

  6. T. Tsuchiya and G. Levy. Relationship between dose and plateau levels of drugs eliminated.J. Pharm. Sci. 61: 541–544 (1972).

    Article  CAS  PubMed  Google Scholar 

  7. G. Levy. Kinetics of pharmacologic effects.Clin. Pharmacol. Therap. 7: 362–372 (1966).

    CAS  Google Scholar 

  8. G. Levy. Correlation between drug concentration and drug response in man: Pharmacokinetic considerations.Proc. Fifth Internat. Congr. Pharmacol. 3: 34–55 (1973).

    CAS  Google Scholar 

  9. R. Nagashima, G. Levy, and E. Nelson. Comparative pharmacokinetics of coumarin anticoagulants. I. Unusual interaction of bishydroxycoumarin with plasma proteins-development of a new assay.J. Pharm. Sci. 57: 58–67 (1968).

    Article  CAS  PubMed  Google Scholar 

  10. G. Levy and R. Nagashima. Comparative pharmacokinetics of coumarin anticoagulants. VI. Effect of plasma protein binding on the distribution and elimination of bishydroxycoumarin by rats.J. Pharm. Sci. 58: 1001–1004 (1969).

    Article  CAS  PubMed  Google Scholar 

  11. G. Levy, J. J. Ashley, E. Jahnchen, and D. Perrier. Hydroxylated metabolites as inhibitors of drug biotransformation and their possible roles in dose dependent elimination kinetics.Abst. 13th Natl. Mtg. APhA Acad. Pharm. Sci. 2: 179–180 (1972).

    Google Scholar 

  12. R. Nagashima, R. A. O'Reilly, and G. Levy. Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin.Clin. Pharmacol. Therap. 10: 22–35 (1969).

    CAS  Google Scholar 

  13. G. Levy, R. A. O'Reilly, P. M. Aggeler, and G. M. Keech. Pharmacokinetic analysis of the effect of barbiturate on the anticoagulant action of warfarin in man.Clin. Pharmacol. Therap. 11:372–377 (1970).

    CAS  Google Scholar 

  14. J. N. Eble, B. D. West, and K. P. Link. A comparison of the isomers of warfarin.Biochem. Pharmacol. 15: 1003–1006 (1966).

    Article  CAS  Google Scholar 

  15. A. Breckenridge and M. Orme. The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats.Life Sci. 11: 337–345 (1972).

    Article  CAS  Google Scholar 

  16. D. S. Hewick. Plasma half lives of enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats.J. Pharm. Pharmacol. 24: 661–662 (1972).

    Article  CAS  PubMed  Google Scholar 

  17. R. A. O'Reilly and G. Levy. Kinetics of the anticoagulant effect of bishydroxycoumarin in man.Clin. Pharmacol. Therap. 11: 378–384 (1970).

    Google Scholar 

  18. L. B. Wingard, Jr., and G. Levy. Kinetics of anticoagulant effect of dicumarol in rats.J. Pharmacol. Exptl. Therap. 184: 253–260 (1973).

    CAS  Google Scholar 

  19. R. Nagashima, G. Levy, and E. J. Sarcione. Comparative pharmacokinetics of coumarin anticoagulants. III. Factors affecting the distribution and elimination of bishydroxy-coumarin (BHC) in isolated liver perfusion studies.J. Pharm. Sci. 57: 1881–1888 (1968).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Levy, G. Comparative pharmacokinetics of the anticoagulant effect of coumarin drugs in man and rat. Journal of Pharmacokinetics and Biopharmaceutics 1, 541–551 (1973). https://doi.org/10.1007/BF01059790

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01059790

Key words

Navigation